Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve

NACompletedINTERVENTIONAL
Enrollment

756

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2007

Conditions
Heart Valve Diseases
Interventions
DEVICE

Mitroflow Aortic Heart Valve

Replacement of the native aortic valve or a previously implanted prosthetic aortic valve

Trial Locations (26)

10595

Westchester County Med Ctr, Valhalla

17033

Hershey Medical Center, Hershey

19096

Lankenau Hospital, Wynnewood

19104

Hospital of the Univ. of PA, Philadelphia

21204

St. Joseph's Medical Center, Towson

21287

Johns Hopkins Hospital, Baltimore

23507

Sentara Norfolk General Hospital, Norfolk

46206

Methodist Hospital, Indianapolis

46240

Heart Center of Indiana, Indianapolis

53215

St. Luke's Hospital, Kansas City

St. Luke's Medical Center, Milwaukee

55905

Mayo Clinic, Rochester

75075

Medical Center of Plano, Plano

75246

Baylor Univ. Medical Center, Dallas

76210

Denton Regional Medical, Denton

85006

Banner Good Samaritan, Phoenix

85724

The University of Arizona, Tucson

92123

Sharp Memorial Hospital, San Diego

97225

Providence St. Vincent, Portland

07102

Saint Michael's Med. Center, Newark

07112

Newark Beth Israel Med Ctr, Newark

T2N 2T9

Foothills Medical Centre, Calgary

B3H 3A7

Queen Elizabeth II Health Sciences Centre, Halifax

M4N 3M5

Sunnybrook and Women's College Health Sciences Centre, Toronto

H1T 1C8

Montreal Heart Institute, Montreal

G1V 4G5

Hopital Laval, Québec

All Listed Sponsors
lead

Sorin Group USA, Inc.

INDUSTRY

NCT00630916 - Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve | Biotech Hunter | Biotech Hunter